| |
|
Drug Related Products News
|
RBC Life Sciences Announces Third Quarter 2009 Results
Fri 8:00 am ET (PR Newswire)
RBC Life Sciences, Inc. , a provider of proprietary nutritional supplements, wound care and pain management products, reported today company-wide net sales of $6.49 million for the quarter ended September 30, 2009, compared to net sales of $9.93 million for the same quarter last year.
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 14B | | Price
/ Earnings: | 50.7 | | Price
/ Book: | 8.9 | | Net
Profit Margin (mrq): | 3.0% | | Price
To Free Cash Flow (mrq): | 79.3 | | Return
on Equity: | 6.9% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 1.3% |
|